retatrutide phase 2 obesity nejm 2023 jastreboff Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a trial Retatrutide Just Broke Every Obesity

The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis

Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong

Although clinical trials have so far failed to demonstrate relevant clinical benefits of antioxidant (such as vitamin C, vitamin E, and -lipoic acid) to treat T2DM 34 , here we show that TdGSH can fully prevent LOsG/ROS-induced detrimental effects on -cells

The goal is habits you can maintain, not workouts you dread

Dijon mustard

Aydin S, Benian A, Madazli R, Uludag S, Uzun H, Kaya S: Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia